Drugs / Danshu Capsules
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02833103 Comparator | Jul 2016 → Feb 2018 | biliary dyskinesia | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Danshu Capsules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02833103 ↗ |
| Route | Oral | “Danshu Capsules (0.9g potid/day) for three months by oral” NCT02833103 ↗ |